Link to: Optimum Perspectives Podcast
The Optimum Perspectives Podcast
EP#24 – Listen to Lara Campana, VP of Research Operations at Resolution Therapeutics discuss the company’s pioneering macrophage therapies for liver diseases.
8th August 2024
Optimum TV
Bringing you bitesize content from life science leaders hosted by Optimum’s very own Stephen Adams. Talking trends, innovation, capital markets and more…
15th August 2024
Link to: Optimum’s 17th Annual Healthcare Investor Conference 2025
Optimum’s 16th Annual Healthcare Conference 2024
Thursday, 10th October 2024, London.
The agenda has dropped! Now in its 16th year, the half-day conference brings together top executives and business leaders from the life sciences and investment communities.
20th August 2024
Insights
We’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
Novo Holdings invests £50m in UK-Listed Oxford Nanopore Technologies
/in InsightsWeekly wrap-up: Novo Holdings leads $105 million financing of Magenta Medical to support FDA approval for world’s smallest heart pump
/in InsightsAsceneuron secures $100m Series C financing to progress neurodegeneration research, Novo Holding leads round with participation from existing investor Sofinnova Partners
/in InsightsNovo Holdings co-leads £90 million ($114 million) Series A financing for Myricx Bio to advance a novel payload class for antibody-drug conjugates
/in InsightsNovo Holdings invests in MATR Foods’ expansion within plant-based fungi food
/in InsightsOptimum’s weekly round-up: From an investment in AI-based solutions for sustainable agriculture to new data from hepatocellular carcinoma therapy!
/in Insights